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Summary
Background: Limited epidemiological evidence suggests that low maternal iron sta-
tus and anaemia in pregnancy may increase the risk of childhood respiratory and
allergic outcomes.
Objectives: To investigate the relation between maternal haemoglobin concentra-
tions in pregnancy and childhood respiratory and allergic outcomes.
Methods: In the Avon Longitudinal Study of Parents and Children (ALSPAC), we
examined associations of maternal haemoglobin concentrations (g/dL) in pregnancy
with hayfever, eczema, wheezing, doctor-diagnosed asthma, allergic sensitisation
and total IgE at 7 years, and with lung function at 8-9 years in the offspring, after
controlling for potential confounders (N = 3234-5335).
Results: Maternal haemoglobin was not associated with offspring hayfever, eczema,
wheezing or asthma. However, the first haemoglobin measurement in pregnancy
(<18 weeks’ gestation) and the last measurement (>28 weeks’ gestation) were negatively
associated with allergic sensitisation (adjusted odds ratio [95% CI] per g/dL 0.91 [0.83 to
0.99] and 0.90 [0.83 to 0.98], respectively). The last haemoglobin measurement was also
negatively associated with total IgE (adjusted geometric mean ratio 0.94 [0.88 to 0.99]).
Anaemia (haemoglobin <11 g/dL) in late pregnancy was negatively associated with forced
vital capacity (difference in standard deviation score0.07 [0.13 to0.01]).
Conclusions and Clinical Relevance: Lower maternal haemoglobin in pregnancy may
be a risk factor for allergic sensitisation, elevated IgE and lower FVC in childhood,
which may reflect effects of lower prenatal iron status. However, maternal haemo-
globin was not associated with risk of childhood asthma or other allergic disorders.
K E YWORD S
allergic sensitisation, ALSPAC, anaemia, birth cohort, haemoglobin
1 | BACKGROUND
There is a substantial body of epidemiological evidence implicating the
prenatal environment in the aetiology of childhood respiratory and
allergic disorders,1 and there has been considerable interest in the
possible role of maternal nutrition during pregnancy.2 One potentially
modifiable risk factor which has received relatively little attention is
iron deficiency, which is common in pregnant women in the West.3
Prenatal iron deficiency could plausibly influence respiratory and aller-
gic outcomes by causing prematurity and impaired foetal growth;
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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gestational age at delivery and offspring birthweight are associated
with maternal haemoglobin concentration,4 as well as with offspring
wheezing, asthma, eczema, allergic sensitisation and impaired lung
function.5-8 Also, animal data suggest that an adequate supply of iron
is required for optimal lung, and particularly airway, development.9
The first clues that prenatal iron status might be important came
from the Avon Longitudinal Study of Parents and Children (ALSPAC),
the study used in this paper, in which we found that umbilical cord
iron concentration in over 2000 participants was negatively associ-
ated with wheezing and eczema in early childhood.10 More recently,
another UK birth cohort study (Study of Eczema and Asthma to
Observe the influence of Nutrition, SEATON) reported results of
exploratory analyses in a small subgroup (n = 157) of that cohort.
The authors found some evidence to suggest that different indica-
tors of lower maternal iron status in early gestation were associated
with an increased risk of wheezing and lower lung function in the
offspring at 10 years of age, although findings were inconsistent
across the different indicators, and no associations were found with
asthma or eczema.11 A small study from the USA (n = 97) suggested
that poor foetal iron status may increase the risk of infant
eosinophilia.12
Iron deficiency is the commonest cause of anaemia in preg-
nancy.13,14 A study from the USA (N = 597) specifically investigated
the relation between anaemia in pregnancy and respiratory out-
comes in childhood, and found that maternal anaemia was positively
associated with risk of early childhood wheezing; positive associa-
tions were also found with persistent wheezing and asthma at
6 years of age, but only amongst offspring of mothers with
asthma.15 On the other hand, a prospective study conducted in the
Netherlands did not confirm any association between maternal hae-
moglobin levels during pregnancy and wheezing in early childhood or
asthma outcomes at the age of 6 years.16
In the population-based ALSPAC birth cohort, we have investi-
gated whether lower maternal haemoglobin concentrations in preg-
nancy, as a proxy for low prenatal iron status, are associated with an
increased risk of respiratory and allergic outcomes in childhood.
2 | METHODS
2.1 | Participants
The Avon Longitudinal Study of Parents and Children (ALSPAC) is a
population-based birth cohort that recruited 14 541 predominantly
white pregnant women resident in Avon, UK with expected dates of
delivery 1st April 1991 to 31st December 1992. Of these pregnan-
cies, there were 14 676 fetuses, resulting in 14 062 live births and
13 978 singleton or twin children who were alive at 1 year of age.
Of these, 13 758 had maternal obstetric information abstracted from
medical records. The cohort has been followed since birth with
annual questionnaires and, since age 7 years, with objective mea-
sures in annual research clinics. The study protocol has been
described previously,17,18 and further information can be found at:
http://www.alspac.bris.ac.uk. Please note that the study website
contains details of all the data that are available through a fully
searchable data dictionary: http://www.bris.ac.uk/alspac/researche
rs/data-access/data-dictionary/. Ethics approval for all aspects of
data collection was obtained from the ALSPAC Ethics and Law Com-
mittee (IRB 00003312) and the Local NHS Research Ethics Commit-
tees. Written consent was obtained for clinic measurements.
2.2 | Maternal haemoglobin in pregnancy
All blood haemoglobin measurements which were taken as part of rou-
tine antenatal care were abstracted from the women’s obstetric
records by six trained research midwives. There was no between-mid-
wife variation in mean values of the data abstracted and error rates
were consistently <1% in repeated data entry checks. There was a
median of 3 measurements of haemoglobin per woman (interquartile
range of 2 to 3). Gestational age at each measurement was calculated
from the date of measurement and the final clinical estimate of the
expected date of delivery abstracted from obstetric records. We
derived the first haemoglobin as the haemoglobin measurement with
the earliest gestational age for each woman, provided that this was
before 18 weeks of gestation. If there was not a measurement prior to
18 weeks of gestation, this variable was treated as missing. We
derived the last haemoglobin as the haemoglobin measurement with
the latest gestational age, provided that this was after 28 weeks of
gestation, otherwise this variable was set to missing. Anaemia after
28 weeks of gestation was defined according to WHO criteria, namely
a haemoglobin concentration <11 g/dL.14 Few women were anaemic
by this definition before 18 weeks of gestation.
2.3 | Outcomes
When the children were 7.5 years old, mothers were asked: “Has
your child had any of the following in the past 12 months: wheezing;
asthma; eczema; hayfever?.” Children were defined as having current
doctor-diagnosed asthma at 7.5 years if mothers responded posi-
tively to the question “Has a doctor ever actually said that your
study child has asthma?” and positively to one or both of the ques-
tions on wheezing and asthma in the past 12 months.
Allergic sensitisation at 7 years was defined as a positive reac-
tion (any detectable weal) to D. pteronyssinus, cat or grass (after sub-
tracting positive saline reactions from histamine and allergen weals,
and excluding children unreactive to 1% histamine). (Allergic sensiti-
sation defined in this way identified 96% of children sensitized to 26
other allergens in this cohort19). Serum total IgE (kU/L) was mea-
sured by fluoroimmunoassay using the Pharmacia UNICAP system
(Pharmacia & Upjohn Diagnostics AB, Uppsala, Sweden).
Lung function was measured by spirometry (Vitalograph 2120) at
age 8½ years after withholding short-acting bronchodilators for at
least 6 hours and long-acting bronchodilators and theophyllines for
at least 24 hours. The best of three reproducible flow-volume curves
was used to measure FEV1, FVC and maximal mid-expiratory flow
(FEF25-75). Lung function measurements were transformed to age,
height and gender-adjusted standard deviation units.20 The tests
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adhered to American Thoracic Society (ATS) criteria for standardisa-
tion and reproducibility of flow-volume measurement,21 with the
exception of ATS recommendations for duration of expiration22; as
many children did not fulfil forced expiratory time >6 seconds end
of test criteria, a minimal volume change over the final 1 second
was used.
2.4 | Maternal covariates
Maternal age at delivery was abstracted from obstetric records.
Information on maternal asthma, eczema, pre-pregnancy weight and
height, parity, smoking status, highest educational qualification and
ethnicity was obtained from questionnaires administered during
pregnancy. Pre-pregnancy body mass index (BMI) was calculated as
weight(kg)/height(m)2 and classed according to World Health Organi-
sation definitions of underweight (<18.5 kg/m2), normal (18.5-
24.9 kg/m2), overweight (25.0-29.9 kg/m2) and obese (≥30.0 kg/m2).
Smoking status was categorised as: “Never” for women who did not
smoke regularly immediately prior to or during pregnancy; “pre-preg-
nancy/first trimester” for women who smoked immediately prior to
pregnancy or in the first 3 months and then stopped; and “through-
out” for women who continued to smoke after the first 3 months.
Maternal highest educational qualification was categorised as Certifi-
cate of Secondary Education (CSE)/vocational (exams usually taken
when the participants were aged 16 years, the legal minimal age that
children could leave school at that time), O level (ordinary-level; also
taken at 16 but more academically challenging than CSE), A level
(advanced-level; taken at age 18 for those staying on at school and
required to enter higher education and for some professional occu-
pations), or university degree. Maternal ethnicity was categorised as
white or non-white.
2.5 | Statistical analysis
We compared the distributions of child and maternal variables across
quintiles of first and last maternal haemoglobin in pregnancy, as well
as between those who had complete data on all exposure, outcome
and co-variables to be included in the analysis and those excluded
because of missing data, using one-way analysis of variance to test
for differences in the means of continuous variables and chi-squared
tests for differences in the categorical variables.
We used logistic regression to relate maternal haemoglobin to
binary offspring outcomes: hayfever, eczema, wheezing, asthma and
allergic sensitisation, and we present odds ratios for these outcomes.
Linear regression was used to relate maternal haemoglobin to con-
tinuous offspring outcomes: FEV1, FVC and FEF25-75 SD scores and
IgE. FEV1, FVC and FEF25-75 SD scores were normally distributed
and we present mean differences in these outcomes for different
levels of maternal haemoglobin (with null value 0), while IgE was nat-
ural log-transformed and we present ratios of geometric means for
this outcome. We fitted separate regression models with maternal
first or last haemoglobin as the exposure. We analysed maternal
haemoglobin as a categorical exposure, using quintiles of
haemoglobin, to allow for a non-linear pattern of association (setting
the middle quintile as the reference category, given reports that
maternal haemoglobin has a U-shape association with other out-
comes such as low birth weight and pre-term birth4), and separately
as a continuous exposure to test for trend. Secondarily, we analysed
anaemia after 28 weeks of gestation as a binary exposure.
For all regression analyses, three stages of adjustment were
used. In Model 1, we adjusted for the gestational age at the haemo-
globin measurement and offspring sex only. In Model 2, we adjusted
additionally for potential maternal confounders, namely maternal
asthma, eczema, pre-pregnancy BMI, age, parity, smoking during
pregnancy, highest educational qualification, twin pregnancy and eth-
nicity. In Model 3, we adjusted additionally for gestational age at
delivery and offspring birthweight, which are associated with mater-
nal haemoglobin concentration,4 as well as with offspring wheezing,
asthma, eczema, allergic sensitisation and impaired lung function,5-8
and could mediate the relation between maternal haemoglobin and
childhood outcomes. We have made some key assumptions which
are necessary for mediation analysis, namely that there is no interac-
tion between the exposures and mediators23 and no unmeasured
confounding of the mediator-outcome associations.24 Online supple-
ment Figure S1 shows a directed acyclic graph to illustrate potential
confounders and mediators of the associations between maternal
haemoglobin and childhood outcomes.
In view of previous observations,15 we tested whether the asso-
ciations between maternal haemoglobin and each of the outcomes
were modified by maternal asthma, by testing for an interaction term
using likelihood ratio tests. All statistical analyses were completed
using Stata version 13.1 (StataCorp LP, USA).
3 | RESULTS
Figure S2 shows the participant flow in the ALSPAC birth cohort,
and numbers of mother/child pairs with complete data according to
childhood outcomes. Characteristics of mothers and offspring who
were included in the analyses of each childhood outcome and who
were excluded from all analyses because of incomplete data are
shown in supplementary Table S1. Mothers with incomplete data
were more likely to be smokers, less well educated, multiparous,
younger and non-white, than mothers who were included. Excluded
offspring had lower lung function, birthweight and IgE, and a lower
prevalence of hayfever, eczema and allergic sensitisation, and a
higher prevalence of wheezing and asthma than those who were
included, although differences were small.
Table 1 shows the distribution of maternal and offspring charac-
teristics, including respiratory and allergic outcomes, according to the
quintiles of first haemoglobin measurement in pregnancy. First haemo-
globin measurements were higher when taken earlier in gestation and
were positively correlated with last haemoglobin measurements, and
negatively with anaemia in late pregnancy. There was weak evidence
for an association between haemoglobin measurements and childhood
allergic sensitisation, but not with prevalence of other respiratory or
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TABLE 1 Characteristics of mothers and offspring who had information on at least one set of outcome variables (questionnaire-based,
asthma, allergic sensitisation, IgE or lung function) by quintiles of the mother’s first pregnancy haemoglobin measurement (total N = 7,270)
Total
N (%)
Quintiles of first haemoglobin % or mean (SD)
P for
difference1st(≤11.8 g/dL)
2nd (11.9-12.3
g/dL) 3rd(12.4-12.7 g/dL) 4th(12.8-13.2 g/dL) 5th(≥13.3 g/dL)
Gestation at
first
haemoglobin
(wk)
7270 10.8 (2.9) 10.3 (2.6) 10.1 (2.6) 9.9 (2.5) 9.6 (2.5) <.001
Last maternal
haemoglobin
(g/dL)
7270 11.03 (0.91) 11.24 (0.82) 11.40 (0.82) 11.54 (0.88) 11.87 (0.93) <.001
Gestation at
last
haemoglobin
(wk)
7270 34.5 (3.1) 34.3 (3.0) 34.3 (3.1) 34.2 (3.1) 34.4 (3.2) .13
Late
pregnancy
anaemia
7270
No 5006 52.7 63.5 71.8 75.6 85.1 <.001
Yes 2264 47.3 36.5 28.2 24.4 14.9
Hayfever 6189
No 5639 90.3 91.2 90.8 91.1 92.3
Yes 550 9.7 8.8 9.2 8.9 7.7 .53
Eczema 6204
No 5177 83.8 83.8 83.1 82.5 83.9
Yes 1027 16.2 16.2 16.9 17.5 16.1 .85
Wheezing 6219
No 5551 89.3 88.6 89.0 88.7 90.7
Yes 668 10.7 11.4 11.0 11.3 9.3 .48
Asthma 6163
No 4895 80.0 77.3 81.2 79.3 79.8
Yes 1268 20.0 22.7 18.8 20.7 20.2 .19
Allergic
sensitisation
4956
No 3908 78.6 75.9 80.5 80.2 79.7
Yes 1048 21.4 24.1 19.5 19.8 20.3 .07
IgE (ku/L)a 3772 59.7 (20.9, 179.0) 55.5 (21.2, 210.0) 55.4 (21.4, 178.0) 60.3 (21.3, 189.0) 59.5 (18.2, 201.0) .83
FEV1 SD
scoreb
5076 0.02 (1.00) 0.01 (1.00) 0.00 (0.98) 0.03 (1.00) 0.02 (0.99) .97
FVC SD scoreb 5149 0.00 (1.00) 0.00 (1.00) 0.04 (0.99) 0.01 (0.99) 0.01 (1.00) .80
FEF25-75 SD
scoreb
5149 0.02 (0.98) 0.01 (0.97) 0.04 (1.02) 0.01 (1.00) 0.00 (1.03) .65
Gender 7270
Male 3749 51.8 52.6 51.8 49.6 51.9
Female 3521 48.2 47.4 48.2 50.4 48.1 .55
Multiple
pregnancy
7270
Singleton 7106 96.5 98.6 97.4 98.2 98.2
Twin 164 3.5 1.4 2.6 1.8 1.8 .001
(Continues)
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allergic outcomes in the offspring. Mothers with the lowest haemoglo-
bin concentrations were more likely to have twin pregnancies, to be
non-white, multiparous and older; they also had a lower BMI and a
lower prevalence of asthma. Associations with the last haemoglobin
measurement in pregnancy were broadly similar, although mothers
with the highest haemoglobin measurements were more likely to have
twin pregnancies, to be older, to be better educated and to have lower
birthweight babies (Table S2). Mean first haemoglobin concentrations
were higher than mean last haemoglobin concentrations (prevalence
of anaemia 4.8% and 31.1%, respectively).
Figure 1 and Table S3 and S4 show that neither first, nor last,
haemoglobin measurements were associated with hayfever, eczema,
wheezing or asthma in the offspring when haemoglobin was anal-
ysed as a continuous variable. Compared to mothers who were in
the middle quintile for first haemoglobin measurement, those in the
top quintile were less likely to have children who wheezed; this find-
ing did not change on controlling for confounders or after further
adjustment for gestational age and weight at birth (Table S3).
Figure 1 and Table 2 show that both first and last haemoglobin
measurements were negatively associated with allergic sensitisation
TABLE 1 (Continued)
Total
N (%)
Quintiles of first haemoglobin % or mean (SD)
P for
difference1st(≤11.8 g/dL)
2nd (11.9-12.3
g/dL) 3rd(12.4-12.7 g/dL) 4th(12.8-13.2 g/dL) 5th(≥13.3 g/dL)
Maternal
ethnicity
6960
White 6829 96.8 98.1 98.5 98.6 98.8
Non-white 131 3.2 1.9 1.5 1.4 1.2 <.001
Maternal BMI
(kg/m2)
6563 22.36 (3.48) 22.66 (3.41) 22.93 (3.66) 23.21 (3.74) 23.84 (4.48) <.001
Maternal age
(y)
7270 28.93 (4.63) 28.93 (4.49) 28.79 (4.58) 28.78 (4.61) 28.34 (4.64) .003
Maternal
parity
7014
Nulliparous 3304 41.8 43.7 47.3 49.3 54.9
Multiparous 3710 58.2 56.3 52.7 50.7 45.1 <.001
Maternal
smoking in
pregnancy
7069
Never 5146 70.4 74.5 73.4 73.7 72.3
1st trimester 857 12.1 12.2 13.6 11.2 11.6
Throughout 1066 17.5 13.3 13.0 15.1 16.1 .01
Maternal
education
6991
CSE/
vocational
1720 25.1 23.6 23.6 24.8 25.8
O level 2510 35.4 36.0 34.8 35.9 37.4
A level 1739 25.1 26.4 24.8 23.2 24.6
Degree 1022 14.3 14.1 16.7 16.1 12.1 .11
Maternal
asthma
7002
No 6242 91.3 90.2 88.2 87.8 87.6
Yes 760 8.7 9.8 11.8 12.2 12.4 .003
Maternal
eczema
7002
No 5370 77.1 78.9 78.0 74.7 74.7
Yes 1632 22.9 21.1 22.0 25.3 25.3 .02
Gestational
age (wk)a
7270 40 (39, 41) 40 (39, 41) 40 (39, 41) 40 (39, 41) 40 (39, 41) .92
Birthweight (g) 7213 3442.4 (536.3) 3456.0 (509.1) 3445.0 (527.6) 3446.3 (533.2) 3404.2 (557.1) .10
aMedian (interquartile range) is presented due to the skewed distributions of these variables.
bLung function SD scores are standardised by age, sex and height.
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in the offspring after controlling for confounders. Children of moth-
ers in the top quintile for last haemoglobin measurement were 25%
less likely to be sensitized than those of mothers in the middle quin-
tile. Last haemoglobin was also negatively associated with total IgE
(Figure 2 and Table S5). These associations were unchanged on con-
trolling additionally for gestational age and weight at birth. There
was weak evidence for a positive association between last haemo-
globin and offspring FVC, after controlling for confounders, which
was not attenuated by controlling additionally for gestational age
and weight at birth (Figure 2 and Table S6).
In secondary analyses, we analysed associations with anaemia in
late pregnancy. Anaemia was associated with a lower risk of eczema
(Table S7), and there was weak evidence for a positive association
with asthma (Table S8), but no association with allergic sensitisation
or IgE (Table S9 and S10). Anaemia was associated with lower FVC
(Table 3). We also tested whether the associations between
maternal haemoglobin and each of the outcomes were modified by
maternal asthma, but there was no evidence of interaction (all
P-values for interaction >.01; full stratified results available from
authors on request).
4 | DISCUSSION
In this large population-based birth cohort, we found that a lower
maternal haemoglobin concentration in pregnancy was associated
with an increased risk of allergic sensitisation and elevated IgE in the
offspring. Lower haemoglobin and anaemia were also associated
with lower FVC. A previous, much smaller, study of 597 mother-
child pairs by Triche et al in the USA reported that maternal anaemia
measured prior to delivery was positively associated with risk of per-
sistent wheezing and asthma at 6 years of age, but only amongst
F IGURE 1 Associations of first and last maternal haemoglobin measurements in pregnancy with binary offspring outcomes. Adjusted for
offspring sex, gestational age at the time of the haemoglobin measure, maternal asthma, maternal eczema, maternal pre-pregnancy BMI,
maternal age, maternal parity, maternal smoking during pregnancy, maternal education, multiple pregnancy and maternal ethnicity (Model 2)
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offspring of mothers with asthma.15 In ALSPAC, we found no associ-
ation with asthma in the whole cohort when analysing haemoglobin
as a continuous variable throughout pregnancy, although there was
weak evidence for a positive association between anaemia in late
pregnancy and asthma. However, we found no evidence for effect
modification by maternal asthma. Given that our study was an order
of magnitude larger, and hence had much greater statistical power,
we think that the findings of the American study may have arisen by
chance. That study did not investigate relations with allergic sensiti-
sation or IgE. Furthermore, a large birth cohort study in the Nether-
lands also found no relation between maternal haemoglobin in
pregnancy and offspring asthma.16 The only other study to examine
the relation between maternal haemoglobin and childhood respira-
tory and allergic outcomes, including allergic sensitisation, analysed
data from a very small subset of the Scottish SEATON cohort. How-
ever, statistical power was extremely limited by the small sample size
(n = 157 mother-child pairs), and because the exposure was analysed
only as a dichotomous variable; no association was found between
low maternal haemoglobin at delivery and any outcome.11 Whilst
our analyses of anaemia and allergic sensitisation did not support
the results for maternal haemoglobin analysed as a continuous vari-
able, this may be because there was less statistical power when ana-
lysing a binary exposure and outcome.
One interpretation of our findings for maternal haemoglobin in
pregnancy is that lower prenatal iron status increases the risk of
allergic sensitisation and lower lung function in children of school
age. However, to our knowledge, the only study to investigate this
directly was the SEATON study, which analysed the relation
between three different indicators of maternal iron status measured
in early gestation and at delivery, and multiple respiratory and aller-
gic outcomes in the offspring.11 Whilst one indicator of lower iron
status measured at birth was positively associated with childhood
allergic sensitisation, this may have been a chance finding, as the
other indicators were not, and none of the indicators measured in
early pregnancy were associated with allergic sensitisation. That
study did, however, find some evidence for an association between
lower prenatal iron status and lower lung function.
4.1 | Mechanisms
If lower prenatal iron status does cause an increased risk of allergic
sensitisation in childhood, we speculate that this might occur
through persistence of Th2 immune responses postnatally. We
would therefore expect iron status in late pregnancy to be more
influential than in early pregnancy, and we found a clear reduction in
allergic sensitisation amongst children of mothers in the top quintile
for last haemoglobin which was not evident for first haemoglobin.
However, whilst there are some animal and human data suggesting
that iron deficiency may increase Th2 cytokine responses,25-27 other
studies have not confirmed this.28,29 Furthermore, interpretation of
the direction of iron-cytokine associations is complicated by the fact
that Th1 and Th2 cytokines can influence iron metabolism.30,31
Regarding the weak evidence linking lower maternal haemoglobin
and anaemia to lower lung function, especially FVC, in the offspring,
TABLE 2 Odds ratios (95% confidence interval) for allergic sensitisation associated with maternal first and last haemoglobin measurements
in pregnancy (N = 4,235)a
Model 1
Odds Ratio (95% CI)
Model 2
Odds Ratio (95% CI)
Model 3
Odds Ratio (95% CI)
First haemoglobin
Per g/dL of haemoglobin 0.91 (0.83, 0.98) 0.91 (0.83, 0.99) 0.91 (0.83, 0.99)
Quintiles of haemoglobin
1st quintile 1.06 (0.84, 1.34) 1.06 (0.84, 1.34) 1.06 (0.84, 1.34)
2nd quintile 1.24 (0.99, 1.55) 1.27 (1.01, 1.59) 1.28 (1.02, 1.61)
3rd quintile (reference) 1 1 1
4th quintile 0.94 (0.74, 1.18) 0.93 (0.74, 1.18) 0.93 (0.74, 1.18)
5th quintile 0.92 (0.73, 1.17) 0.94 (0.74, 1.19) 0.94 (0.74, 1.20)
Last haemoglobin
Per g/dL of haemoglobin 0.92 (0.85, 1.00) 0.90 (0.83, 0.98) 0.90 (0.83, 0.98)
Quintiles of haemoglobin
1st quintile 0.97 (0.78, 1.21) 0.99 (0.79, 1.24) 1.00 (0.80, 1.26)
2nd quintile 0.88 (0.71, 1.11) 0.89 (0.71, 1.12) 0.89 (0.71, 1.12)
3rd quintile (reference) 1 1 1
4th quintile 0.85 (0.67, 1.06) 0.83 (0.66, 1.05) 0.83 (0.66, 1.05)
5th quintile 0.78 (0.62, 0.98) 0.75 (0.59, 0.94) 0.76 (0.60, 0.96)
aModel 1 is adjusted for offspring sex and gestational age at the time of the haemoglobin measure; Model 2 is additionally adjusted for maternal
asthma, maternal eczema, maternal pre-pregnancy BMI, maternal age, maternal parity, maternal smoking during pregnancy, maternal education, multiple
pregnancy and maternal ethnicity; Model 3 is additionally adjusted for gestational age at birth and birthweight.
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there is some evidence from animal experiments suggesting that an
adequate supply of iron is needed for optimal lung development.9
Adjusting for birthweight and gestational age did not attenuate the
associations of maternal haemoglobin with allergic sensitisation, IgE
and lung function, suggesting that these associations were not medi-
ated by impaired foetal growth overall. However, lower birth weight
is a crude proxy measure of impaired foetal lung growth, which
could still have mediated the relation between lower maternal hae-
moglobin and anaemia and lower childhood lung function.
4.2 | Strengths and limitations
Aside from ALSPAC’s size and population-based prospective design,
a strength of our study is that maternal haemoglobin was objectively
measured as part of routine antenatal care and abstracted from the
women’s obstetric records, thus reducing the likelihood of selection
or measurement bias. However, haemoglobin, which provides a mea-
sure of the functional use of iron, has two limitations as a biomarker
of iron status in pregnancy. Firstly, whilst iron deficiency is the com-
monest cause of anaemia in pregnancy,13 mothers may be anaemic
but not iron-deficient, and conversely they may be mildly iron-defi-
cient and not anaemic.13 Secondly, haemoglobin concentrations vary
as plasma volume increases during gestation, leading to haemodilu-
tion, with the greatest dilution and lowest haemoglobin concentra-
tions occurring in the second trimester.13,32 However, as the
haemoglobin measurements used in our analyses were in the first
and last trimesters, we think that haemodilution is unlikely to have
influenced them to a great extent. Whilst we did not have measure-
ments of other biomarkers of maternal iron status, such as plasma
ferritin, plasma transferrin saturation, or serum soluble transferrin
receptor and its ratio to ferritin,33 no single marker of iron metabo-
lism is considered ideal for assessment of iron deficiency, as each
has limitations in terms of sensitivity and specificity.32,34,35 A partic-
ular limitation of ferritin, which is an indirect indicator of total body
iron stores, is that it is an acute phase reactant and will increase in
the presence of inflammation.36 If, however, our findings for
F IGURE 2 Associations of first and last maternal haemoglobin measurements in pregnancy with continuous offspring outcomes. Adjusted
for offspring sex, gestational age at the time of the haemoglobin measure, maternal asthma, maternal eczema, maternal pre-pregnancy BMI,
maternal age, maternal parity, maternal smoking during pregnancy, maternal education, multiple pregnancy and maternal ethnicity (Model 2)
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maternal haemoglobin do reflect effects of underlying iron defi-
ciency, and given that misclassification of iron deficiency using hae-
moglobin as a biomarker is likely to be random with respect to
childhood outcomes, then it is likely we will have underestimated
effects of prenatal iron deficiency using maternal haemoglobin as a
proxy marker.
Given the number of statistical tests carried out, we acknowl-
edge that the main findings could have arisen by chance; it would
therefore be of interest to see whether they can be replicated in
other large birth cohorts. Whilst we cannot rule out the possibility
that our main findings might be explained by uncontrolled or residual
confounding, we controlled for a large number of potential con-
founders. We acknowledge that there may have been some misclas-
sification of maternally-reported outcomes, however, as
misclassification of outcome is likely to be non-differential with
respect to the exposure of interest, this would be expected to bias
effect estimates towards the null; in other words, the magnitude of
associations might be underestimated. As with any longitudinal
study, data were not complete on exposures, outcomes and con-
founders for the whole cohort. Therefore, we cannot rule out the
possibility that exclusion of children without complete information
might have biased our findings. However, we can see no reason why
associations between maternal haemoglobin and the outcomes of
interest would be different in those included and those excluded.
In conclusion, we have found some evidence to suggest that a
lower maternal haemoglobin concentration in pregnancy is associ-
ated with an increased risk of allergic sensitisation, elevated IgE and
lower FVC in the offspring. To test whether these findings reflect
causal effects of prenatal iron deficiency, we plan to use a Mendelian
randomisation approach, whereby maternal genotype will be used as
a proxy for prenatal iron status. This approach has been used previ-
ously in ALSPAC to examine the association between maternal iron
status and a different childhood outcome.37 Confirmation of a causal
link could raise exciting possibilities for primary prevention through
iron supplementation in pregnancy.
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